United Kingdom

People: Alliqua BioMedical Inc (ALQA.OQ)

ALQA.OQ on NASDAQ Stock Exchange Capital Market

23 Mar 2018
Change (% chg)

$-0.02 (-1.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Pionati, Nino 

Mr. Nino Pionati is the Chief Strategy & Marketing Officer of Alliqua BioMedical, Inc., effective June 15, 2015. Mr. Pionati joined the Company from Bayer HealthCare Pharmaceuticals, where he served as the Vice President of Marketing for the Essure portfolio and a member of the Global Franchise and Women’s Health Care Leadership teams from May 2014 until May 2015. From March 2013 to May 2014, he was the president of 4P’s Advisors LLC, a management consulting firm focused on strategy development, new product development and marketing for companies in the medical technology and healthcare industry. From 1998 until December 2012, Mr. Pionati served a 14 year tenure at ConvaTec, Inc., a privately held global medical device company spun out of Bristol Myers Squibb, Inc., where he held several global marketing and management level positions, including President of Global Marketing, Business Development and International and President of the Intercontinental Region. Prior to joining ConvaTec, Inc., he held a variety of positions at Johnson & Johnson, Inc. in sales, service, clinical regulatory and marketing and co-led the development of an internally-backed startup, J&J Independence Technologies. Mr. Pionati holds an MBA from the University of Pittsburg’s Katz School of Business and a Bachelors of Commerce in Marketing from Concordia University of Montreal.

Basic Compensation

Total Annual Compensation, USD 340,800
Restricted Stock Award, USD 86,000
Long-Term Incentive Plans, USD --
All Other, USD 8,400
Fiscal Year Total, USD 435,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --